Genus, Meet Species: Court Weighs Novo Nordisk’s Semaglutide Patent
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court…
1,294 articles
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court…
Dr. Kalyan Kankanala's two new Oxford titles, Patents in India and Copyrights in India, are now open for international pre-order. Set for a December 2026 release, both books…
The Delhi High Court dismissed BlackBerry's appeal against the refusal of its patent for colour-coding email recipients on handheld devices, holding that the invention lacked inventive step and…
Novartis AG sought a quia timet patent injunction against Intas Pharmaceuticals Limited before the Delhi High Court, alleging that regulatory filings and an investigation report revealed imminent infringement…
Titan Company Limited took its rejected “Jewellery Assembly” application to the Madras High Court, testing whether a cost-saving gemstone arrangement was patent or design subject matter. Did the…
Fraunhofer's bioreactor patent application met rejection at the Calcutta High Court's IP Division, which weighed whether biological material disclosure of source and geographical origin is mandatory under the…
The Delhi High Court sets aside the Controller’s blanket refusal of an FTIR spectral analysis patent for skin cancer tissue characterization, holding that the Controller misapplied the Section…
Patent attorneys and agents carry knowledge, skill, and experience that the patent system depends on. They are not mere conduits for the filing of documents. They are professionals…
In the case of Shaafi Naturcure LLP v Assistant Controller of Patents and Designs, the applicant claimed that six known herbs, when combined in specific proportions, produced a…
The Delhi High Court's Division Bench held that product-to-claim mapping is indispensable for patent infringement, even in anticipatory suits. In a dispute between Zydus Lifesciences and E.R. Squibb…